Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Intergen, |
RCV003479548 | SCV004218536 | likely pathogenic | Pyruvate kinase deficiency of red cells | 2024-01-01 | criteria provided, single submitter | clinical testing | PP3-S, PM2 |
Ambry Genetics | RCV004364824 | SCV005006258 | uncertain significance | Inborn genetic diseases | 2024-01-16 | criteria provided, single submitter | clinical testing | The c.754G>A (p.V252M) alteration is located in exon 6 (coding exon 6) of the PKLR gene. This alteration results from a G to A substitution at nucleotide position 754, causing the valine (V) at amino acid position 252 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |